SEC Comment Letter for Co-Diagnostics, Inc. (CODX) (CIK 0001692415) (CODX) — Aug 29, 2018
Co-Diagnostics, Inc. (CODX) (CIK 0001692415)
Date: Aug. 29, 2018 · CIK: 0001692415 · Accession: 0000000000-18-026897
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-226835
Letter
August 29, 2018 Dwight Egan Chief Executive Officer, President and Director Co-Diagnostics, Inc. 2401 S. Foothill Drive Salt Lake City, Utah 84109 Re:Co-Diagnostics, Inc. Registration Statement on Fom S-3 Filed August 14, 2018 File No. 333-226835 Dear Mr. Egan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Thomas Jones at 202-551-3602 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery cc: Peter DiChiara, Esq.
Show Raw Text
August 29, 2018
Dwight Egan
Chief Executive Officer, President and Director
Co-Diagnostics, Inc.
2401 S. Foothill Drive
Salt Lake City, Utah 84109
Re:Co-Diagnostics, Inc.
Registration Statement on Fom S-3
Filed August 14, 2018
File No. 333-226835
Dear Mr. Egan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Thomas Jones at 202-551-3602 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Peter DiChiara, Esq.